Valeo Pharma Inc (FRA:VP2)

€ 0.005 0 (0%) Market Cap: 493,000.00 Enterprise Value: 43.05 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q3 2024 Valeo Pharma Inc Earnings Call Transcript
Sep 13, 2024

€0.0245 (+188.24%)

Earnings
Q2 2024 Valeo Pharma Inc Earnings Call Transcript
Jun 14, 2024

€0.08 (+64.95%)

Earnings
Q1 2024 Valeo Pharma Inc Earnings Call Transcript
Mar 15, 2024

€0.106 (+0.95%)

Earnings
Q4 2023 Valeo Pharma Inc Earnings Call Transcript
Jan 30, 2024

€0.202 (-6.48%)

Earnings
Q2 2023 Valeo Pharma Inc Earnings Call Transcript
Jun 14, 2023

€0.242 (+11.01%)

Earnings
Valeo Pharma Inc at Bloom Burton & Co Healthcare Investor Conference Transcript
Apr 25, 2023
Q1 2023 Valeo Pharma Inc Earnings Call Transcript
Mar 16, 2023

€0.334

Earnings
Valeo Pharma Inc at OTC Markets Life Science Investor Forum (Virtual) Transcript
Mar 09, 2023
Q2 2022 Valeo Pharma Inc Earnings Call Transcript
Jun 15, 2022

€0.396 (+7.61%)

Earnings
Valeo Pharma Inc at Bloom Burton & Co. Healthcare Investor Conference Transcript
May 03, 2022
Q1 2022 Valeo Pharma Inc Earnings Call Transcript
Mar 25, 2022

€0.473 (-0.84%)

Earnings
Q3 2021 Valeo Pharma Inc Earnings Call Transcript
Sep 23, 2021

€0.463 (-2.11%)

Earnings
Q2 2021 Valeo Pharma Inc Earnings Call Transcript
Jun 30, 2021

Earnings
Q1 2021 Valeo Pharma Inc Earnings Call Transcript
Apr 01, 2021

€0.746 (-7.90%)

Earnings
Q4 2020 Valeo Pharma Inc Earnings Call Transcript
Feb 25, 2021

€0.67 (-6.94%)

Earnings

Q2 2024 Valeo Pharma Inc Earnings Call Transcript

Jun 14, 2024 / 12:30PM GMT

Release Date Price: €0.08 (+64.95%)

Transcript

Operator

Good morning, ladies and gentlemen, and welcome to the Valeo Pharma, Inc., second quarter results conference call. (Operator Instructions) This call is being recorded on Friday, June 14, 2024.

I would now like to turn the conference over to Frederic Dumais. Please go ahead.

Frederic Dumais

Valeo Pharma Inc - Director Communications and Investor Relations

Thank you, operator. Good morning, everyone. Present with me today for our second quarter 2024 financial results conference call are Mr. Steve Saviuk, our CEO, and Mr. Pascal Tougas, our Chief Financial Officer.

Before we begin our call, I would like to remind everyone that this conference call may contain certain forward-looking statements regarding the company's expectations of future events. Such expectations are based on certain assumptions that are founded on currently available information. If these assumptions prove incorrect, actual results may differ materially from those contemplated by the forward-looking statements contained in this conference call. The company disclaims any

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.